BACKGROUND: The urinary tract is the most common source for Escherichia coli bacteremia. Mortality from E. coli urinary-source bacteremia is higher than that from urinary tract infection. Predisposing factors for urinary-source E. coli bacteremia are poorly characterized. METHODS: In order to identify urinary-source bacteremia risk factors, we conducted a 12-month prospective cohort study of adult inpatients with E. coli bacteriuria that were tested for bacteremia within ±1 day of the bacteriuria. Patients with bacteremia were compared with those without bacteremia. Bacterial isolates from urine were screened for 16 putative virulence genes using high-throughput dot-blot hybridization. RESULTS: Twenty-four of 156 subjects (15%) had E. coli bacteremia. Bacteremic patients were more likely to have benign prostatic hyperplasia (56% vs 19%; P = .04), a history of urogenital surgery (63% vs 28%; P = .001), and presentation with hesitancy/retention (21% vs 4%; P = .002), fever (63% vs 38%; P = .02), and pyelonephritis (67% vs 41%; P = .02). The genes kpsMT (group II capsule) (17 [71%] vs 62 [47%]; P = .03) and prf (P-fimbriae family) (13 [54%] vs 40 [30%]; P = .02) were more frequent in the urinary strains from bacteremic patients. Symptoms of hesitancy/retention (odds ratio [OR], 7.8; 95% confidence interval [CI], 1.6-37), history of a urogenital procedure (OR, 5.4; 95% CI, 2-14.7), and presence of kpsMT (OR, 2.9; 95% CI, 1-8.2) independently predicted bacteremia. CONCLUSIONS: Bacteremia secondary to E. coli bacteriuria was frequent (15%) in those tested for it. Urinary stasis, surgical disruption of urogenital tissues, and a bacterial capsule characteristic contribute to systemic invasion by uropathogenic E. coli.
BACKGROUND: The urinary tract is the most common source for Escherichia colibacteremia. Mortality from E. coli urinary-source bacteremia is higher than that from urinary tract infection. Predisposing factors for urinary-source E. coli bacteremia are poorly characterized. METHODS: In order to identify urinary-source bacteremia risk factors, we conducted a 12-month prospective cohort study of adult inpatients with E. coli bacteriuria that were tested for bacteremia within ±1 day of the bacteriuria. Patients with bacteremia were compared with those without bacteremia. Bacterial isolates from urine were screened for 16 putative virulence genes using high-throughput dot-blot hybridization. RESULTS: Twenty-four of 156 subjects (15%) had E. coli bacteremia. Bacteremic patients were more likely to have benign prostatic hyperplasia (56% vs 19%; P = .04), a history of urogenital surgery (63% vs 28%; P = .001), and presentation with hesitancy/retention (21% vs 4%; P = .002), fever (63% vs 38%; P = .02), and pyelonephritis (67% vs 41%; P = .02). The genes kpsMT (group II capsule) (17 [71%] vs 62 [47%]; P = .03) and prf (P-fimbriae family) (13 [54%] vs 40 [30%]; P = .02) were more frequent in the urinary strains from bacteremic patients. Symptoms of hesitancy/retention (odds ratio [OR], 7.8; 95% confidence interval [CI], 1.6-37), history of a urogenital procedure (OR, 5.4; 95% CI, 2-14.7), and presence of kpsMT (OR, 2.9; 95% CI, 1-8.2) independently predicted bacteremia. CONCLUSIONS:Bacteremia secondary to E. coli bacteriuria was frequent (15%) in those tested for it. Urinary stasis, surgical disruption of urogenital tissues, and a bacterial capsule characteristic contribute to systemic invasion by uropathogenic E. coli.
Authors: James R Johnson; Michael A Kuskowski; Abby Gajewski; Sara Soto; Juan Pablo Horcajada; M Teresa Jimenez de Anta; Jordi Vila Journal: J Infect Dis Date: 2004-11-30 Impact factor: 5.226
Authors: James R Johnson; Flemming Scheutz; Peter Ulleryd; Michael A Kuskowski; Timothy T O'Bryan; Torsten Sandberg Journal: Clin Infect Dis Date: 2005-02-16 Impact factor: 9.079
Authors: Marco Ripa; Laura Morata; Olga Rodríguez-Núñez; Celia Cardozo; Pedro Puerta-Alcalde; Marta Hernández-Meneses; Juan Ambrosioni; Laura Linares; Marta Bodro; Andrea Valcárcel; Climent Casals; Maria de Los Angeles Guerrero-León; Manel Almela; Carolina Garcia-Vidal; Ana Del Río; Francesc Marco; Josep Mensa; José Antonio Martínez; Alex Soriano Journal: Antimicrob Agents Chemother Date: 2018-10-24 Impact factor: 5.191
Authors: Drew J Schwartz; Vasilios Kalas; Jerome S Pinkner; Swaine L Chen; Caitlin N Spaulding; Karen W Dodson; Scott J Hultgren Journal: Proc Natl Acad Sci U S A Date: 2013-09-03 Impact factor: 11.205
Authors: Rituparna Das; Lakshman Subrahmanyan; Ivana V Yang; David van Duin; Rebecca Levy; Marta Piecychna; Lin Leng; Ruth R Montgomery; Albert Shaw; David A Schwartz; Richard Bucala Journal: J Infect Dis Date: 2013-10-24 Impact factor: 5.226
Authors: Robin R Shields-Cutler; Jan R Crowley; Chia S Hung; Ann E Stapleton; Courtney C Aldrich; Jonas Marschall; Jeffrey P Henderson Journal: J Biol Chem Date: 2015-04-10 Impact factor: 5.157
Authors: Raina N Fichorova; Noah Beatty; Rita R S Sassi; Hidemi S Yamamoto; Elizabeth N Allred; Alan Leviton Journal: Am J Reprod Immunol Date: 2014-08-28 Impact factor: 3.886